Using a mouse preclinical pancreatic cancer model, Zhou and colleagues have shown that it is possible to inhibit galectin-9 expression in the host following the intravenous injection of galectin-9-specific siRNA-loaded exosomes (66). This evidence concerns the gene LGALS9 and pancreatic neoplasm.